Britain has enrolled more than 5,000 COVID-19 patients, or 10 percent of the country's cases, in a clinical trial to test out several drugs to treat the new coronavirus. The Recovery trial, conducted at 165 National Health Service hospitals, is "by far the largest trial in the world," Peter Horby, the Oxford University infectious disease professor leading it, told The Guardian. With such a large number of subjects, "we're guessing some time in June we may get the results," though "if it is really clear that there are benefits, an answer will be available quicker," he added.
The study has randomly split the subjects into groups of 500 to 900 to test different drugs, with 2,000 patients getting placebos in a control group. Among the drugs being tested — first individually, but later perhaps in different combinations — are the anti-malaria drug hydroxychloroquine, the antibiotic azithromycin, two HIV antiretroviral drugs (lopinavir-ritonavir), and the anti-inflammatory steroid dexamethasone. Horby said his team will include other drugs soon and hopes to obtain a supply of the experimental antiviral drug remdesivir.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Do smartphone bans in schools work?The Explainer Trials in UK, New Zealand, France and the US found prohibition may be only part of the solution
-
Doom: The Dark Ages – an 'exhilarating' prequelThe Week Recommends Legendary shooter adds new combat options from timed parries to melee attacks and a 'particularly satisfying' shield charge
-
7 US cities to explore on a microtripThe Week Recommends Not enough vacation days? No problem.
-
Warren Buffet announces surprise retirementspeed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff displaySpeed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loomSpeed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panelsSpeed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of businessSpeed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
-
Trump's China tariffs start after Canada, Mexico pausesSpeed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
-
Chinese AI chatbot's rise slams US tech stocksSpeed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor dealSpeed Read The strike could have shut down major ports from Texas to Maine
